Healthcare provider profile · identity verified

Jonathan Musyt, MD

Family Practice · EPHRATA, PA · NPI 1033556253

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	269	79
Amlodipine Besylate	Amlodipine Besylate	153	42
Lisinopril	Lisinopril	149	43
Rosuvastatin Calcium	Rosuvastatin Calcium	148	45
Losartan Potassium	Losartan Potassium	132	39
Metformin Hcl	Metformin Hcl	119	34
Omeprazole	Omeprazole	119	35
Gabapentin	Gabapentin	118	37
Simvastatin	Simvastatin	103	28
Oxycodone Hcl	Oxycodone Hcl	100	16
Hydrochlorothiazide	Hydrochlorothiazide	99	27
Pantoprazole Sodium	Pantoprazole Sodium	99	26
Alprazolam	Alprazolam	85	18
Zolpidem Tartrate	Zolpidem Tartrate	85	13
Furosemide	Furosemide	82	30
Levothyroxine Sodium	Levothyroxine Sodium	78	26
Lorazepam	Lorazepam	76	18
Metoprolol Succinate	Metoprolol Succinate	74	25
Tramadol Hcl	Tramadol Hcl	72	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	62	17
Famotidine	Famotidine	59	19
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	57	suppressed
Sertraline Hcl	Sertraline Hcl	57	17
Trulicity	Dulaglutide	57	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	55	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	53	26
Montelukast Sodium	Montelukast Sodium	50	17
Clonazepam	Clonazepam	49	suppressed
Eliquis	Apixaban	49	11
Jardiance	Empagliflozin	48	suppressed
Duloxetine Hcl	Duloxetine Hcl	47	11
Metformin Hcl Er	Metformin Hcl	46	14
Bupropion Xl	Bupropion Hcl	45	13
Mirtazapine	Mirtazapine	45	12
Metoprolol Tartrate	Metoprolol Tartrate	43	15
Allopurinol	Allopurinol	41	14
Trazodone Hcl	Trazodone Hcl	41	suppressed
Meloxicam	Meloxicam	38	12
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	37	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Prednisone	Prednisone	36	27
Synthroid	Levothyroxine Sodium	35	12
Clopidogrel	Clopidogrel Bisulfate	34	13
Buspirone Hcl	Buspirone Hcl	31	suppressed
Glipizide	Glipizide	30	suppressed
Azelastine Hcl	Azelastine Hcl	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	11
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	27	suppressed
Potassium Chloride	Potassium Chloride	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	17
Naproxen	Naproxen	25	11
Ozempic	Semaglutide	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Carvedilol	Carvedilol	24	suppressed
Estradiol	Estradiol	24	suppressed
Fluconazole	Fluconazole	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	14
Cephalexin	Cephalexin	23	19
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Fentanyl	Fentanyl	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Torsemide	Torsemide	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	20
Baclofen	Baclofen	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Movantik	Naloxegol Oxalate	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Diazepam	Diazepam	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	20	suppressed
Atenolol	Atenolol	19	suppressed
Finasteride	Finasteride	19	suppressed
Promethazine Hcl	Promethazine Hcl	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	13
Valsartan	Valsartan	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Azithromycin	Azithromycin	13	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Clonidine Hcl	Clonidine Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Klayesta	Nystatin	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error